Drugs company AstraZeneca has announced that it is ready to quickly produce 30 million vaccines, if the test turns out to be a success.
However, experts have warned that the Uk may have to wait several months before they can get their hands on it.
Here’s everything you need to know about the coronavirus vaccine, including what stage it is, and when it is probable that you will be able to get it.
What is the status of the coronavirus vaccine trial the?
The Oxford trial is currently in Phase II and Phase III.
The first phase of the trial at the University of Oxford began in April, and included 1,000 adult volunteers.
Now, more than 10,000 volunteers with over 70 years of age and 5 to 12 years old – were enrolled in the second phase of the trial.
Speaking last month, Professor Andrew Pollard, head of the Oxford Vaccine Group, said: “clinical studies are progressing very well and we are now initiating studies to assess the effectiveness of the vaccine-induced immune responses in older adults, and to determine if she can provide protection in the general population.
“We are very grateful to the tremendous support of volunteers to help test if this new vaccine could protect humans against the pandemic of sars coronavirus.”
During this time, the vaccine is also being tested in South Africa, it was announced this week.
Dr. Sandile Buthelezi, the Director-General of Health in South Africa the National Department of Health, said: “The National board of Health is excited at the opportunity to launch this trial of a vaccine, which will go a long way to cement South Africa’s leadership in space science.
“With COVID-19 infections is increasing every day, the development of the vaccine will be the last solution in the long term, and we are fully behind the team conducting this trial.”
What is the vaccine?
The vaccine, called ChAdOx1 nCoV-19, is manufactured from a virus ChAdOx1, which is a weakened version of the common cold virus that causes infections in chimpanzees, which has been genetically modified, so that it is possible to grow in humans.
The researchers explained: “By the vaccination with ChAdOx1 nCoV-19, we hope to make the body to recognize and develop an immune response to the Spike protein that will help stop the SARS-CoV-2 virus from entering human cells and, therefore, to prevent infection.”
When the results of the trial will be available?
Unfortunately, it remains difficult to know when the results of the study will be available.
The researchers explained: “How quickly we reach the number required will depend on the rate of transmission of the virus in the community.
“If the transmission remains high, we can obtain enough data in a couple of months to see if the vaccine works, but if the levels of transmission of a fall, it can take up to 6 months.
“The recruitment of those who are the most likely to be exposed to SARS-CoV-2 virus is a priority, such as front-line care workers first-line support to staff and the public in the face of key people, in an effort to capture the efficacy data as quickly as possible.”
When are you going to be able to receive the vaccine?
While early reports indicate that the vaccine could be available as early as August, experts have now warned, it may not be ready until October.
Speaking during a webinar this week, Professor Adrian Hill, director of the Institute Jenner at the University of Oxford, explained that the “best-case” scenario to see the results of the trial in August and September, with deliveries from October.
The delay is due to the fact that infection rates are now so low in the united KINGDOM, according to Professor Sara Gilbert, who is at the forefront of the search.
She explained: “We had hoped to have enough people vaccinated before the epidemic reached a peak, but the virus spread quickly, triggering a lockdown, and infection rates are now falling. At least some of the trial participants become infected, we may not know that the vaccine is effective.
“We are therefore focusing on the vaccination of health care workers, because they have the highest rate of infections by the virus. In addition, as measures to facilitate the locking are introduced, the transmission can rise again.
“We need to manufacture more of the vaccine for testing, and the plan to begin testing in more than one country to give us the best chance to determine the effectiveness of the vaccine.”
What does it mean for you?
A vaccine could provide some protection against the virus of the formation of your immune system to fight.
This would allow the lock to be lifted more safely, and social distancing to be relaxed.
If the trial is a success, it will not be long before the vaccine becomes available in the UK.
AstraZeneca has said that it has the capacity to manufacture one billion doses of the University of Oxford ‘s potential Covid-19 vaccine and to start procurement in September.